{
    "organizations": [],
    "uuid": "3d31d1437f9c8d30b253bad1cf8fd661f6aad034",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-daiichi-sankyo-initiates-phase-2-s/brief-daiichi-sankyo-initiates-phase-2-study-of-ds-8201-idUSFWN1QP0I3",
    "ord_in_thread": 0,
    "title": "BRIEF-Daiichi Sankyo Initiates Phase 2 Study Of DS-8201",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 7 (Reuters) - Daiichi Sankyo Co Ltd:\n* DAIICHI SANKYO INITIATES PHASE 2 STUDY OF DS-8201 IN PATIENTS WITH HER2-EXPRESSING ADVANCED COLORECTAL CANCER Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-07T21:16:00.000+02:00",
    "crawled": "2018-03-08T17:28:39.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "daiichi",
        "sankyo",
        "co",
        "ltd",
        "daiichi",
        "sankyo",
        "initiate",
        "phase",
        "study",
        "patient",
        "advanced",
        "colorectal",
        "cancer",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}